| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
| X25-04-YM1053-1 |
PEG 350 Da |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-2 |
PEG 550 Da |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-3 |
PEG 750 Da |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-4 |
PEG 1 kDa |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-5 |
PEG 2 kDa |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-6 |
PEG 3 kDa |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-7 |
PEG 4 kDa |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-8 |
PEG 5 kDa |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-9 |
PEG 10 kDa |
Alginate |
Raltitrexed |
Inquiry
|
| X25-04-YM1053-10 |
PEG 20 kDa |
Alginate |
Raltitrexed |
Inquiry
|
Properties
Description
Alginate-PEG-raltitrexed (raltitrexed-PEG-alginate) merges alginate’s biodegradability with the anticancer drug raltitrexed via PEG. Variable PEG sizes (350–20k Da) boost aqueous compatibility, sustain circulation, and control drug liberation rates.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Stability
It is stable under its storage temperature.
Quality Level
Research level
Applications
Alginate-PEG-raltitrexed plays a key role in mimicking casein micelle structures for nutrient delivery system design.
Storage
Store at -20°C, protect from light and moisture.